{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:57:12Z","timestamp":1769853432341,"version":"3.49.0"},"reference-count":24,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"Supplement","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-351","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T22:42:06Z","timestamp":1426718526000},"page":"S17-S21","source":"Crossref","is-referenced-by-count":26,"title":["Pulmonary Arterial Hypertension Associated With Tetralogy of Fallot"],"prefix":"10.1536","volume":"56","author":[{"given":"Jun","family":"Yasuhara","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Cardiology, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Cardiology, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. D\u2019Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Resp Rev 2012; 21: 328-37. (Review)","DOI":"10.1183\/09059180.00004712"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007; 115: 163-72.","DOI":"10.1161\/CIRCULATIONAHA.106.627224"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-36. (Review)","DOI":"10.1056\/NEJMra040291"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99: 1858-65.","DOI":"10.1161\/01.CIR.99.14.1858"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005; 111: 3274-80.","DOI":"10.1161\/CIRCULATIONAHA.104.473371"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mukhopadhyay S, Sharma M, Ramakrishnan S, <i>et al<\/i>. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation 2006; 114: 1807-10.","DOI":"10.1161\/CIRCULATIONAHA.105.603001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gali\u00e8 N, Beghetti M, Gatzoulis MA, <i>et al<\/i>. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48-54.","DOI":"10.1161\/CIRCULATIONAHA.106.630715"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gatzoulis MA, Beghetti M, Gali\u00e8 N, <i>et al<\/i>. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol 2008; 127: 27-32.","DOI":"10.1016\/j.ijcard.2007.04.078"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Berger RM, Beghetti M, Gali\u00e8 N, <i>et al<\/i>. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger\u2019s syndrome: a subgroup analysis. Int J Cardiol 2010; 144: 373-8.","DOI":"10.1016\/j.ijcard.2009.04.037"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baumgartner H, Bonhoeffer P, De Groot NM, <i>et al<\/i>. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57.","DOI":"10.1093\/eurheartj\/ehq249"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Simonneau G, Robbins IM, Beghetti M, <i>et al<\/i>. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-54. (Review)","DOI":"10.1016\/j.jacc.2009.04.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ivy DD, Abman SH, Barst RJ, <i>et al<\/i>. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013; 62: D117-26. (Review)","DOI":"10.1016\/j.jacc.2013.10.028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yamaki S, Horiuchi T. Quantitative analysis of postoperative changes in the pulmonary vasculature of patients with complete transposition of the great arteries and pulmonary hypertension. Am J Cardiol 1979; 44: 284-9.","DOI":"10.1016\/0002-9149(79)90318-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Roisman ML, Beller BM, O\u2019Keefe JD. Irreversible pulmonary hypertension after correction of tetralogy of Fallot. Chest 1972; 62: 34-8.","DOI":"10.1378\/chest.62.1.34"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Leonard H, Derrick G, O\u2019Sullivan J, Wren C. Natural and unnatural history of pulmonary atresia. Heart 2000; 84: 499-503.","DOI":"10.1136\/heart.84.5.499"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mair DD, Puga FJ. Management of pulmonary atresia with ventricular septal defect. Curr Treat Options Cardiovasc Med 2003; 5: 409-15.","DOI":"10.1007\/s11936-003-0047-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Reddy VM, McElhinney DB, Amin Z, <i>et al<\/i>. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. Circulation 2000; 101: 1826-32.","DOI":"10.1161\/01.CIR.101.15.1826"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Maeda J, Yamagishi H, Matsuoka R, <i>et al<\/i>. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 2000; 92: 269-72.","DOI":"10.1002\/(SICI)1096-8628(20000605)92:4<269::AID-AJMG9>3.0.CO;2-L"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamagishi H. The 22q11.2 deletion syndrome. Keio J Med 2002; 51: 77-88. (Review)","DOI":"10.2302\/kjm.51.77"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yamagishi H, Srivastava D. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med 2003; 9: 383-9. (Review)","DOI":"10.1016\/S1471-4914(03)00141-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Thiene G, Frescura C, Bini RM, Valente M, Gallucci V. Histology of pulmonary arterial supply in pulmonary atresia with ventricular septal defect. Circulation 1979; 60: 1066-74.","DOI":"10.1161\/01.CIR.60.5.1066"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamamura K, Nagata H, Ikeda K, Ihara K, Hara T. Efficacy of bosentan therapy for segmental pulmonary artery hypertension due to major aortopulmonary collateral arteries in children. Int J Cardiol 2012; 161: e1-3. (Review)","DOI":"10.1016\/j.ijcard.2012.03.021"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lim ZS, Vettukattill JJ, Salmon AP, Veldtman GR. Sildenafil therapy in complex pulmonary atresia with pulmonary arterial hypertension. Int J Car-diol 2008; 129: 339-43.","DOI":"10.1016\/j.ijcard.2007.08.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schermuly RT, Pullamsetti SS, Kwapiszewska G, <i>et al<\/i>. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy. Circulation 2007; 115: 2331-9.","DOI":"10.1161\/CIRCULATIONAHA.106.676809"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:37:00Z","timestamp":1498203420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/Supplement\/56_14-351\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":24,"journal-issue":{"issue":"Supplement","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-351","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}